Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value
XenoTherapeutics Inc. and Xeno Acquisition Corp, a non-profit biotechnology company, on Friday agreed to acquire Repare Therapeutics Inc. (NASDAQ:RPTX).
Benzinga ·